Development and validation of novel scoring system for the prediction of disease recurrence following resection of colorectal liver metastasis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Wan-Joon | - |
dc.contributor.author | Lim, Tae-Wan | - |
dc.contributor.author | Kang, Sang-Hee | - |
dc.contributor.author | Park, Pyoung-Jae | - |
dc.contributor.author | Choi, Sae-Byeol | - |
dc.contributor.author | Lee, Sun-il | - |
dc.contributor.author | Min, Byung-Wook | - |
dc.contributor.author | Kim, Wan-Bae | - |
dc.date.accessioned | 2022-03-15T17:42:14Z | - |
dc.date.available | 2022-03-15T17:42:14Z | - |
dc.date.created | 2021-12-24 | - |
dc.date.issued | 2020-02 | - |
dc.identifier.issn | 1015-9584 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/139092 | - |
dc.description.abstract | Background: The aim of this study was to identify predictive factors for the recurrence of colorectal cancer liver metastasis (CRLM) and then to develop a corresponding novel scoring system that should improve the sensitivity of predicting recurrence in patients with CRLM. Methods: A total of 295 consecutive CRLM patients were enrolled in our institution between January 2002 and December 2015. Multivariate analyses were performed to identify the variables associated with disease recurrence and established the novel scoring system based on it. Results: The scoring system considered seven variables: synchronosity, CA19-9 level, number of liver metastasis, largest size of liver metastasis, resection margin of hepatic lesion, neutrophil-to-lymphocyte ratio and prognostic nutritional index. The area under the curve of ROC was 0.824 (95% confidence interval 0.767-0.882); the sensitivity of our scoring system was 87.9%, specificity was 66.7%, positive predictive value was 20.6%, and negative predictive value was 20.9%. Conclusion: For patients with CRLM undergoing curative hepatic resection, our novel scoring system would improve the sensitivity for prediction of disease recurrence in Case of CRLM patients. (C) 2019 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SINGAPORE PTE LTD | - |
dc.subject | HEPATIC RESECTION | - |
dc.subject | PROGNOSTIC-FACTORS | - |
dc.subject | CLINICAL SCORE | - |
dc.subject | CANCER | - |
dc.subject | SURVIVAL | - |
dc.subject | CHEMOTHERAPY | - |
dc.subject | HEPATECTOMY | - |
dc.subject | LYMPHOCYTE | - |
dc.subject | OUTCOMES | - |
dc.subject | SURGERY | - |
dc.title | Development and validation of novel scoring system for the prediction of disease recurrence following resection of colorectal liver metastasis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Wan-Joon | - |
dc.contributor.affiliatedAuthor | Kang, Sang-Hee | - |
dc.contributor.affiliatedAuthor | Park, Pyoung-Jae | - |
dc.contributor.affiliatedAuthor | Choi, Sae-Byeol | - |
dc.contributor.affiliatedAuthor | Lee, Sun-il | - |
dc.contributor.affiliatedAuthor | Min, Byung-Wook | - |
dc.contributor.affiliatedAuthor | Kim, Wan-Bae | - |
dc.identifier.doi | 10.1016/j.asjsur.2019.06.001 | - |
dc.identifier.scopusid | 2-s2.0-85070679567 | - |
dc.identifier.wosid | 000509485100006 | - |
dc.identifier.bibliographicCitation | ASIAN JOURNAL OF SURGERY, v.43, no.2, pp.438 - 446 | - |
dc.relation.isPartOf | ASIAN JOURNAL OF SURGERY | - |
dc.citation.title | ASIAN JOURNAL OF SURGERY | - |
dc.citation.volume | 43 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 438 | - |
dc.citation.endPage | 446 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | CLINICAL SCORE | - |
dc.subject.keywordPlus | HEPATECTOMY | - |
dc.subject.keywordPlus | HEPATIC RESECTION | - |
dc.subject.keywordPlus | LYMPHOCYTE | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | PROGNOSTIC-FACTORS | - |
dc.subject.keywordPlus | SURGERY | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordAuthor | CA19-9 | - |
dc.subject.keywordAuthor | CRLM | - |
dc.subject.keywordAuthor | Disease free survival | - |
dc.subject.keywordAuthor | NLR | - |
dc.subject.keywordAuthor | Scoring system | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.